| histone acetylation | GO:0016573 | 41 | 0.999 | Human Yeast Fly |
| chromatin organization | GO:0006325 | 206 | 0.998 | Human Yeast Fly |
| internal peptidyl lysine acetylation | GO:0018393 | 42 | 0.996 | Human Yeast Fly |
| chromatin modification | GO:0016568 | 187 | 0.991 | Human Yeast Fly |
| histone h4 acetylation | GO:0043967 | 10 | 0.991 | Human |
| positive regulation of dna templated transcription elongation | GO:0032786 | 2 | 0.991 | |
| histone modification | GO:0016570 | 159 | 0.991 | Human Yeast Fly |
| gene silencing by mirna | GO:0035195 | 10 | 0.983 | |
| peptidyl lysine modification | GO:0018205 | 77 | 0.976 | Human Yeast Fly |
| protein acylation | GO:0043543 | 64 | 0.969 | Human Yeast Fly |
| histone h3 acetylation | GO:0043966 | 14 | 0.969 | |
| internal protein amino acid acetylation | GO:0006475 | 42 | 0.958 | Human Yeast Fly |
| peptidyl lysine acetylation | GO:0018394 | 45 | 0.956 | Human Yeast Fly |
| histone h4 k12 acetylation | GO:0043983 | 2 | 0.943 | |
| regulation of transcription during meiosis | GO:0051037 | 1 | 0.941 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.934 | Human Yeast Fly |
| protein dna complex subunit organization | GO:0071824 | 28 | 0.907 | Fly |
| positive regulation of transcription elongation from rna polymerase ii promoter | GO:0032968 | 2 | 0.904 | |
| histone h3 k14 acetylation | GO:0044154 | 3 | 0.875 | |
| male meiosis i | GO:0007141 | 16 | 0.773 | |
| stem cell fate specification | GO:0048866 | 3 | 0.759 | |
| histone deubiquitination | GO:0016578 | 2 | 0.730 | Human |
| regionalization | GO:0003002 | 337 | 0.720 | Fly |
| dna metabolic process | GO:0006259 | 303 | 0.719 | Yeast |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.675 | |
| histone h3 k4 methylation | GO:0051568 | 23 | 0.640 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.597 | Human Yeast Fly |
| heterocycle catabolic process | GO:0046700 | 280 | 0.508 | |
| regulation of histone modification | GO:0031056 | 56 | 0.484 | |
| positive regulation of gene silencing by mirna | GO:2000637 | 1 | 0.443 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.339 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.319 | |
| gene silencing by rna | GO:0031047 | 19 | 0.317 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.316 | |
| male meiosis | GO:0007140 | 37 | 0.294 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.265 | Yeast |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.262 | |
| regulation of histone h3 k4 methylation | GO:0051569 | 12 | 0.233 | |
| histone lysine methylation | GO:0034968 | 50 | 0.221 | |
| dna repair | GO:0006281 | 107 | 0.218 | Yeast |
| histone h4 k16 acetylation | GO:0043984 | 3 | 0.210 | |
| gene silencing | GO:0016458 | 38 | 0.200 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.180 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.170 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.168 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.165 | |
| mrna catabolic process | GO:0006402 | 22 | 0.149 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.149 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.148 | |
| blastocyst development | GO:0001824 | 80 | 0.147 | |
| segmentation | GO:0035282 | 93 | 0.140 | |
| transcription elongation from rna polymerase ii promoter | GO:0006368 | 9 | 0.140 | |
| mrna metabolic process | GO:0016071 | 84 | 0.139 | |
| positive regulation of posttranscriptional gene silencing | GO:0060148 | 1 | 0.137 | |
| forebrain development | GO:0030900 | 302 | 0.135 | |
| regulation of rna splicing | GO:0043484 | 37 | 0.134 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.132 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.129 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.126 | |
| digestive tract development | GO:0048565 | 190 | 0.122 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.119 | |
| germ cell development | GO:0007281 | 185 | 0.118 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.118 | |
| chromatin remodeling | GO:0006338 | 32 | 0.118 | Fly |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.113 | |
| gland development | GO:0048732 | 330 | 0.112 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.111 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.111 | |
| regulation of response to dna damage stimulus | GO:2001020 | 34 | 0.110 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.109 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.108 | |
| regulation of dna templated transcription elongation | GO:0032784 | 10 | 0.106 | |
| nuclear division | GO:0000280 | 158 | 0.106 | |
| neural tube formation | GO:0001841 | 108 | 0.104 | |
| neural tube closure | GO:0001843 | 90 | 0.104 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.104 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.102 | |
| epithelial tube formation | GO:0072175 | 130 | 0.100 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.099 | |
| regulation of cell cycle g2 m phase transition | GO:1902749 | 10 | 0.098 | |
| pole plasm assembly | GO:0007315 | 2 | 0.097 | |
| neural tube development | GO:0021915 | 160 | 0.096 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.095 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.095 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.095 | |
| neuron projection guidance | GO:0097485 | 141 | 0.094 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.091 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.090 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.090 | |
| regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter | GO:0072364 | 7 | 0.090 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.088 | |
| peptidyl lysine trimethylation | GO:0018023 | 12 | 0.087 | |
| dendrite development | GO:0016358 | 115 | 0.087 | |
| blastocyst growth | GO:0001832 | 23 | 0.086 | |
| neuroblast differentiation | GO:0014016 | 2 | 0.085 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.084 | |
| rna processing | GO:0006396 | 105 | 0.084 | |
| organelle fission | GO:0048285 | 170 | 0.084 | |
| regulation of dna damage checkpoint | GO:2000001 | 3 | 0.083 | |
| meiosis i | GO:0007127 | 60 | 0.083 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.083 | |
| spermatogenesis | GO:0007283 | 284 | 0.082 | |
| neuroblast fate commitment | GO:0014017 | 1 | 0.081 | |
| stem cell differentiation | GO:0048863 | 268 | 0.080 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.079 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.078 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.075 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.075 | |
| regulation of transcription elongation from rna polymerase ii promoter | GO:0034243 | 9 | 0.075 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.074 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.073 | |
| primary neural tube formation | GO:0014020 | 95 | 0.073 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.072 | |
| maintenance of chromatin silencing | GO:0006344 | 2 | 0.072 | |
| dna methylation | GO:0006306 | 43 | 0.072 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.070 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.069 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.068 | |
| inner cell mass cell proliferation | GO:0001833 | 15 | 0.068 | |
| somitogenesis | GO:0001756 | 69 | 0.067 | |
| male gamete generation | GO:0048232 | 285 | 0.067 | |
| chemotaxis | GO:0006935 | 247 | 0.067 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.066 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.066 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.066 | |
| protein catabolic process | GO:0030163 | 221 | 0.066 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.065 | |
| telencephalon development | GO:0021537 | 186 | 0.065 | |
| tubulin deacetylation | GO:0090042 | 4 | 0.062 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.062 | |
| cell fate commitment | GO:0045165 | 210 | 0.061 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.061 | |
| regulation of protein deacetylation | GO:0090311 | 17 | 0.060 | |
| nuclear transcribed mrna catabolic process deadenylation dependent decay | GO:0000288 | 12 | 0.060 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.059 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.059 | |
| axon target recognition | GO:0007412 | 4 | 0.057 | |
| dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator | GO:0006978 | 2 | 0.057 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.056 | |
| tube closure | GO:0060606 | 91 | 0.055 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.055 | |
| methylation | GO:0032259 | 134 | 0.055 | |
| zygotic determination of anterior posterior axis embryo | GO:0007354 | 3 | 0.055 | |
| renal system development | GO:0072001 | 225 | 0.055 | |
| cell division | GO:0051301 | 120 | 0.053 | Fly |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.053 | |
| histone deacetylation | GO:0016575 | 26 | 0.053 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.052 | |
| cellular response to lipid | GO:0071396 | 145 | 0.052 | |
| dna templated transcription elongation | GO:0006354 | 13 | 0.052 | |
| regulation of protein stability | GO:0031647 | 52 | 0.051 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.051 | |
| regulation of histone methylation | GO:0031060 | 30 | 0.051 | |
| regulation of binding | GO:0051098 | 111 | 0.051 | |
| regulation of transcription by chromatin organization | GO:0034401 | 0 | 0.050 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.050 | |
| regulation of dna binding | GO:0051101 | 39 | 0.049 | |
| positive regulation of binding | GO:0051099 | 49 | 0.049 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.048 | |
| regulation of gene silencing by rna | GO:0060966 | 5 | 0.047 | |
| regulation of cell cycle checkpoint | GO:1901976 | 9 | 0.047 | |
| mrna processing | GO:0006397 | 63 | 0.047 | |
| regulation of mrna processing | GO:0050684 | 41 | 0.047 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.047 | |
| somite development | GO:0061053 | 81 | 0.046 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.046 | |
| axonogenesis | GO:0007409 | 274 | 0.046 | |
| axon guidance | GO:0007411 | 141 | 0.046 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.046 | |
| adult behavior | GO:0030534 | 135 | 0.045 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.044 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.044 | |
| camera type eye development | GO:0043010 | 266 | 0.043 | |
| protein maturation | GO:0051604 | 176 | 0.043 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.042 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.042 | |
| stem cell proliferation | GO:0072089 | 117 | 0.042 | |
| tube formation | GO:0035148 | 140 | 0.041 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.041 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.040 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.039 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.039 | |
| digestive system development | GO:0055123 | 200 | 0.039 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.038 | |
| gastrulation | GO:0007369 | 116 | 0.038 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.038 | |
| protein alkylation | GO:0008213 | 81 | 0.037 | |
| notch signaling pathway | GO:0007219 | 71 | 0.037 | Fly |
| mesenchyme development | GO:0060485 | 152 | 0.037 | |
| epithalamus development | GO:0021538 | 2 | 0.036 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.036 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.036 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.036 | |
| rna splicing | GO:0008380 | 54 | 0.036 | |
| regulation of posttranscriptional gene silencing | GO:0060147 | 5 | 0.035 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.035 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.035 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.034 | |
| amine metabolic process | GO:0009308 | 45 | 0.034 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.034 | |
| synaptic transmission | GO:0007268 | 329 | 0.034 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.034 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.034 | |
| learning or memory | GO:0007611 | 148 | 0.034 | |
| skeletal system development | GO:0001501 | 356 | 0.033 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.032 | |
| protein methylation | GO:0006479 | 81 | 0.032 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.031 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.031 | |
| embryonic placenta development | GO:0001892 | 98 | 0.031 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.031 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.031 | |
| atp dependent chromatin remodeling | GO:0043044 | 9 | 0.030 | Fly |
| oogenesis | GO:0048477 | 56 | 0.030 | |
| histone methylation | GO:0016571 | 71 | 0.030 | |
| muscle tissue development | GO:0060537 | 308 | 0.030 | |
| regulation of histone deacetylation | GO:0031063 | 12 | 0.029 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.029 | |
| gonad development | GO:0008406 | 141 | 0.029 | Worm |
| negative regulation of molecular function | GO:0044092 | 258 | 0.029 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.029 | |
| positive regulation of glycolytic process | GO:0045821 | 4 | 0.029 | |
| histone h3 k9 acetylation | GO:0043970 | 5 | 0.028 | |
| respiratory tube development | GO:0030323 | 167 | 0.028 | |
| urogenital system development | GO:0001655 | 261 | 0.028 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.028 | |
| neuronal action potential | GO:0019228 | 54 | 0.028 | |
| multicellular organism growth | GO:0035264 | 161 | 0.028 | |
| lung development | GO:0030324 | 164 | 0.028 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.028 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.027 | |
| dna methylation involved in gamete generation | GO:0043046 | 15 | 0.027 | |
| cartilage development | GO:0051216 | 140 | 0.027 | |
| chromatin assembly or disassembly | GO:0006333 | 16 | 0.027 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.026 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.026 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.026 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.026 | |
| cell recognition | GO:0008037 | 83 | 0.026 | |
| atp metabolic process | GO:0046034 | 75 | 0.026 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.026 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.026 | |
| habituation | GO:0046959 | 3 | 0.026 | |
| axonal fasciculation | GO:0007413 | 15 | 0.026 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.026 | |
| response to alcohol | GO:0097305 | 48 | 0.025 | |
| stem cell development | GO:0048864 | 219 | 0.025 | |
| chromatin silencing | GO:0006342 | 15 | 0.025 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.025 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.025 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.025 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.025 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.025 | |
| compound eye development | GO:0048749 | 1 | 0.025 | |
| regulation of protein processing | GO:0070613 | 96 | 0.025 | |
| bone development | GO:0060348 | 120 | 0.025 | |
| kidney development | GO:0001822 | 213 | 0.024 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.024 | |
| regulation of alternative mrna splicing via spliceosome | GO:0000381 | 8 | 0.024 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.024 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.024 | |
| rna interference | GO:0016246 | 2 | 0.024 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.024 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.024 | |
| spermatid differentiation | GO:0048515 | 115 | 0.023 | |
| protein localization to organelle | GO:0033365 | 185 | 0.023 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.023 | |
| synapse organization | GO:0050808 | 125 | 0.023 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.023 | |
| glial cell differentiation | GO:0010001 | 131 | 0.023 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.023 | |
| regulation of notch signaling pathway | GO:0008593 | 35 | 0.023 | Fly |
| positive regulation of gluconeogenesis by positive regulation of transcription from rna polymerase ii promoter | GO:0035948 | 5 | 0.022 | |
| protein modification by small protein removal | GO:0070646 | 21 | 0.022 | Human |
| organelle localization | GO:0051640 | 179 | 0.022 | |
| glucose metabolic process | GO:0006006 | 92 | 0.022 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.022 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.022 | |
| epithelial cell development | GO:0002064 | 159 | 0.021 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.021 | |
| palate development | GO:0060021 | 76 | 0.021 | |
| positive regulation of histone h3 k9 methylation | GO:0051574 | 4 | 0.021 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.021 | |
| macromolecule deacylation | GO:0098732 | 37 | 0.021 | |
| sensory perception | GO:0007600 | 245 | 0.021 | |
| female gamete generation | GO:0007292 | 74 | 0.021 | |
| stem cell fate commitment | GO:0048865 | 5 | 0.020 | |
| chromatin silencing at rdna | GO:0000183 | 3 | 0.020 | |
| mesonephros development | GO:0001823 | 97 | 0.020 | |
| negative regulation of calcium ion dependent exocytosis | GO:0045955 | 3 | 0.020 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.020 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.020 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.020 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.020 | |
| hexose metabolic process | GO:0019318 | 98 | 0.020 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.020 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.020 | |
| alternative mrna splicing via spliceosome | GO:0000380 | 12 | 0.020 | |
| wound healing | GO:0042060 | 157 | 0.020 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.019 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.019 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.019 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.019 | |
| rhythmic process | GO:0048511 | 174 | 0.019 | |
| regulation of histone h3 k9 methylation | GO:0051570 | 8 | 0.019 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.019 | |
| dna alkylation | GO:0006305 | 43 | 0.019 | |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 17 | 0.019 | |
| intracellular receptor signaling pathway | GO:0030522 | 74 | 0.019 | |
| ear development | GO:0043583 | 200 | 0.019 | |
| lateral inhibition | GO:0046331 | 1 | 0.019 | |
| response to nutrient levels | GO:0031667 | 109 | 0.019 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.019 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.019 | |
| regulation of bmp signaling pathway | GO:0030510 | 60 | 0.019 | |
| sensory perception of sound | GO:0007605 | 97 | 0.019 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.019 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.019 | |
| cellular response to alcohol | GO:0097306 | 23 | 0.018 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.018 | Worm |
| stem cell maintenance | GO:0019827 | 130 | 0.018 | |
| oocyte construction | GO:0007308 | 2 | 0.018 | |
| metencephalon development | GO:0022037 | 89 | 0.018 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.018 | |
| cell adhesion | GO:0007155 | 329 | 0.018 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.018 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.018 | |
| jak stat cascade | GO:0007259 | 42 | 0.018 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.018 | |
| norepinephrine transport | GO:0015874 | 2 | 0.018 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.018 | |
| gtp metabolic process | GO:0046039 | 144 | 0.018 | |
| locomotory behavior | GO:0007626 | 195 | 0.018 | |
| neuron migration | GO:0001764 | 122 | 0.017 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.017 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.017 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.017 | |
| oocyte axis specification | GO:0007309 | 2 | 0.017 | |
| regulation of cell division | GO:0051302 | 76 | 0.017 | |
| cognition | GO:0050890 | 149 | 0.017 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.017 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.017 | |
| blastoderm segmentation | GO:0007350 | 13 | 0.017 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.017 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.017 | |
| protein dna complex disassembly | GO:0032986 | 1 | 0.017 | |
| dna modification | GO:0006304 | 50 | 0.017 | |
| placenta blood vessel development | GO:0060674 | 31 | 0.017 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.017 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.016 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.016 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 75 | 0.016 | |
| cell cycle g2 m phase transition | GO:0044839 | 20 | 0.016 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.016 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.016 | |
| cohesin localization to chromatin | GO:0071921 | 1 | 0.016 | |
| chromatin disassembly | GO:0031498 | 1 | 0.016 | |
| dna integrity checkpoint | GO:0031570 | 28 | 0.016 | |
| limb morphogenesis | GO:0035108 | 149 | 0.016 | |
| regulation of gene silencing by mirna | GO:0060964 | 4 | 0.016 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.016 | |
| cellular homeostasis | GO:0019725 | 240 | 0.016 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.016 | |
| positive regulation of cell cycle process | GO:0090068 | 61 | 0.016 | |
| habenula development | GO:0021986 | 2 | 0.016 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.015 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.015 | |
| oocyte differentiation | GO:0009994 | 35 | 0.015 | |
| negative regulation of gene silencing by rna | GO:0060967 | 1 | 0.015 | |
| microtubule based process | GO:0007017 | 236 | 0.015 | |
| endomembrane system organization | GO:0010256 | 147 | 0.015 | |
| action potential | GO:0001508 | 78 | 0.015 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.015 | |
| tripartite regional subdivision | GO:0007351 | 9 | 0.015 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.015 | |
| endocytosis | GO:0006897 | 168 | 0.015 | Worm Fly |
| head morphogenesis | GO:0060323 | 34 | 0.015 | |
| multi organism behavior | GO:0051705 | 62 | 0.015 | |
| ectodermal cell differentiation | GO:0010668 | 3 | 0.015 | |
| rna splicing via transesterification reactions | GO:0000375 | 43 | 0.015 | |
| negative regulation of androgen receptor signaling pathway | GO:0060766 | 3 | 0.015 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.014 | |
| regulation of jak stat cascade | GO:0046425 | 34 | 0.014 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.014 | |
| sensory perception of mechanical stimulus | GO:0050954 | 107 | 0.014 | |
| negative regulation of gene expression epigenetic | GO:0045814 | 15 | 0.014 | |
| learning | GO:0007612 | 98 | 0.014 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.014 | |
| organelle assembly | GO:0070925 | 177 | 0.014 | |
| cerebral cortex development | GO:0021987 | 86 | 0.014 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.014 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.014 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.014 | |
| regulation of mrna splicing via spliceosome | GO:0048024 | 32 | 0.014 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.014 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.013 | |
| nucleosome positioning | GO:0016584 | 4 | 0.013 | |
| positive regulation of g2 m transition of mitotic cell cycle | GO:0010971 | 5 | 0.013 | |
| epidermis development | GO:0008544 | 187 | 0.013 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.013 | |
| negative regulation of response to dna damage stimulus | GO:2001021 | 10 | 0.013 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.013 | |
| intracellular protein transport | GO:0006886 | 204 | 0.013 | |
| sensory organ boundary specification | GO:0008052 | 1 | 0.013 | |
| mesenchymal cell proliferation | GO:0010463 | 44 | 0.013 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.013 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.013 | |
| rna polymerase ii transcriptional preinitiation complex assembly | GO:0051123 | 3 | 0.013 | |
| histone h3 k4 trimethylation | GO:0080182 | 5 | 0.013 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.013 | |
| appendage development | GO:0048736 | 166 | 0.013 | |
| atp catabolic process | GO:0006200 | 55 | 0.013 | |
| regulation of gluconeogenesis by regulation of transcription from rna polymerase ii promoter | GO:0035947 | 7 | 0.012 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.012 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.012 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.012 | |
| dna templated transcription initiation | GO:0006352 | 13 | 0.012 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.012 | |
| circadian rhythm | GO:0007623 | 114 | 0.012 | |
| regulation of cell motility | GO:2000145 | 236 | 0.012 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.012 | |
| detection of stimulus involved in sensory perception | GO:0050906 | 44 | 0.012 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.012 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.012 | |
| positive regulation of dna binding | GO:0043388 | 14 | 0.012 | |
| hypermethylation of cpg island | GO:0044027 | 3 | 0.012 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.012 | |
| cellular response to starvation | GO:0009267 | 57 | 0.012 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.012 | |
| epithelial to mesenchymal transition | GO:0001837 | 47 | 0.012 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.012 | |
| cellular carbohydrate metabolic process | GO:0044262 | 119 | 0.012 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.012 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.012 | |
| mesoderm development | GO:0007498 | 100 | 0.012 | |
| endoderm formation | GO:0001706 | 20 | 0.012 | |
| positive regulation of synaptic growth at neuromuscular junction | GO:0045887 | 1 | 0.012 | |
| neural retina development | GO:0003407 | 41 | 0.012 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.011 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.011 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.011 | |
| maintenance of location | GO:0051235 | 89 | 0.011 | Worm |
| placenta development | GO:0001890 | 140 | 0.011 | |
| cellular response to sterol | GO:0036315 | 2 | 0.011 | |
| nuclear transcribed mrna poly a tail shortening | GO:0000289 | 7 | 0.011 | |
| cell fate specification | GO:0001708 | 72 | 0.011 | |
| endoderm development | GO:0007492 | 45 | 0.011 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.011 | |
| negative regulation of posttranscriptional gene silencing | GO:0060149 | 1 | 0.011 | |
| bone morphogenesis | GO:0060349 | 78 | 0.011 | |
| ear morphogenesis | GO:0042471 | 118 | 0.011 | |
| regulation of protein complex disassembly | GO:0043244 | 28 | 0.011 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.011 | |
| pharynx development | GO:0060465 | 1 | 0.011 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.011 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.011 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.011 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.011 | |
| negative regulation of nfat protein import into nucleus | GO:0051534 | 3 | 0.011 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.011 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.011 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.011 | |
| genitalia development | GO:0048806 | 37 | 0.011 | Worm |
| mesodermal cell migration | GO:0008078 | 4 | 0.011 | |
| positive regulation of cellular carbohydrate metabolic process | GO:0010676 | 29 | 0.011 | |
| response to estrogen | GO:0043627 | 24 | 0.011 | |
| positive regulation of neuron projection development | GO:0010976 | 79 | 0.011 | |
| gliogenesis | GO:0042063 | 141 | 0.011 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.011 | |
| glucose homeostasis | GO:0042593 | 128 | 0.010 | |
| multi organism reproductive behavior | GO:0044705 | 29 | 0.010 | |
| protein processing | GO:0016485 | 163 | 0.010 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.010 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.010 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.010 | |
| regulation of androgen receptor signaling pathway | GO:0060765 | 3 | 0.010 | |
| anion transport | GO:0006820 | 177 | 0.010 | |
| axon ensheathment | GO:0008366 | 76 | 0.010 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.010 | |
| protein deubiquitination | GO:0016579 | 19 | 0.010 | Human |
| negative regulation of cell development | GO:0010721 | 169 | 0.010 | |
| response to growth factor | GO:0070848 | 198 | 0.010 | |
| anterior posterior axis specification embryo | GO:0008595 | 9 | 0.010 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.010 | |
